CD96 functions as a co‐stimulatory receptor to enhance CD8 <sup>+</sup> T cell activation and effector responses
Eugene Y. Chiang(Gene Therapy Laboratory), Jane L. Grogan(Biogen (United States)), Denise E. de Almeida Nagata(Cancer Research Institute), Youngsu Kwon(Gene Therapy Laboratory), Patricia E. de Almeida(Cancer Research Institute), Keith R. Anderson(Genesys (United States)), Kristin Harden Bowles(Cancer Research Institute), Avantika S. Chitre, Xiangnan Du(Beijing Luhe Hospital Affiliated to Capital Medical University), Søren Warming(Genesys (United States)), Rafael Cubas(Theravance Biopharma (United States)), Stephanie Mittman(Translational Research in Oncology), Brent S. McKenzie, Karl L. Banta(Cancer Research Institute)
Cited by 100
Related Papers
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
|Nature Immunology|2008|1.5k
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
|Cancer Cell|2022|403
Inadequate T follicular cell help impairs B cell immunity during HIV infection
|Nature Medicine|2013|362